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Cyril Pernet
Centre for Clinical Brain Sciences (CCBS), Neuroimaging Sciences, The University of Edinburgh, Edinburgh, UK
Abstract
Although thoroughly criticized, null hypothesis significance testing (NHST)
remains the statistical method of choice used to provide evidence for an effect,
in biological, biomedical and social sciences. In this short tutorial, I first
summarize the concepts behind the method, distinguishing test of significance
(Fisher) and test of acceptance (Newman-Pearson) and point to common
interpretation errors regarding the p-value. I then present the related concepts
of confidence intervals and again point to common interpretation errors. Finally,
I discuss what should be reported in which context. The goal is to clarify
concepts to avoid interpretation errors and propose reporting practices.
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The Null Hypothesis Significance Testing framework
NHST is a method of statistical inference by which an experi-
mental factor is tested against a hypothesis of no effect or no 
relationship based on a given observation. The method is a combi-
nation of the concepts of significance testing developed by Fisher 
in 1925 and of acceptance based on critical rejection regions devel-
oped by Neyman & Pearson in 1928. In the following I am first 
presenting each approach, highlighting the key differences and 
common misconceptions that result from their combination into 
the NHST framework (for a more mathematical comparison, along 
with the Bayesian method, see Christensen, 2005). I next present 
the related concept of confidence intervals. I finish by discussing 
practical aspects in using NHST and reporting practice.
Fisher, significance testing, and the p-value
The method developed by (Fisher, 1934; Fisher, 1955; Fisher, 
1959) allows to compute the probability of observing a result at 
least as extreme as a test statistic (e.g. t value), assuming the null 
hypothesis of no effect is true. This probability or p-value reflects 
(1) the conditional probability of achieving the observed outcome 
or larger: p(Obs≥t|H0), and (2) is therefore a cumulative probabil-
ity rather than a point estimate. It is equal to the area under the 
null probability distribution curve from the observed test statistic 
to the tail of the null distribution (Turkheimer et al., 2004). The 
approach proposed is of ‘proof by contradiction’ (Christensen, 
2005), we pose the null model and test if data conform to it.
In practice, it is recommended to set a level of significance (a theo-
retical p-value) that acts as a reference point to identify significant 
results, that is to identify results that differ from the null-hypothesis 
of no effect. Fisher recommended using p=0.05 to judge whether 
an effect is significant or not as it is roughly two standard devia-
tions away from the mean for the normal distribution (Fisher, 1934 
page 45: ‘The value for which p=.05, or 1 in 20, is 1.96 or nearly 2; 
it is convenient to take this point as a limit in judging whether a 
deviation is to be considered significant or not’). A key aspect of 
Fishers’ theory is that only the null-hypothesis is tested, and 
therefore p-values are meant to be used in a graded manner to 
decide whether the evidence is worth additional investigation 
and/or replication (Fisher, 1971 page 13: ‘it is open to the 
experimenter to be more or less exacting in respect of the smallness 
of the probability he would require […]’ and ‘no isolated experi-
ment, however significant in itself, can suffice for the experimental 
demonstration of any natural phenomenon’). How small the 
level of significance is, is thus left to researchers.
What is not a p-value? Common mistakes
The p-value is not an indication of the strength or magnitude of 
an effect. Any interpretation of the p-value in relation to the effect 
under study (strength, reliability, probability) is wrong, since 
p-values are conditioned on H0. In addition, while p-values are ran-
domly distributed (if all the assumptions of the test are met) when 
there is no effect, their distribution depends of both the population 
effect size and the number of participants, making impossible to 
infer strength of effect from them.
Similarly, 1-p is not the probability to replicate an effect. Often, 
a small value of p is considered to mean a strong likelihood of 
getting the same results on another try, but again this cannot be 
obtained because the p-value is not informative on the effect itself 
(Miller, 2009). Because the p-value depends on the number of 
subjects, it can only be used in high powered studies to inter-
pret results. In low powered studies (typically small number of 
subjects), the p-value has a large variance across repeated samples, 
making it unreliable to estimate replication (Halsey et al., 2015).
A (small) p-value is not an indication favouring a given hypoth-
esis. Because a low p-value only indicates a misfit of the null 
hypothesis to the data, it cannot be taken as evidence in favour of a 
specific alternative hypothesis more than any other possible alterna-
tives such as measurement error and selection bias (Gelman, 2013). 
Some authors have even argued that the more (a priori) implausi-
ble the alternative hypothesis, the greater the chance that a finding 
 is a false alarm (Krzywinski & Altman, 2013; Nuzzo, 2014).
The p-value is not the probability of the null hypothesis p(H0), 
of being true, (Krzywinski & Altman, 2013). This common 
misconception arises from a confusion between the probability of 
an observation given the null p(Obs≥t|H0) and the probability of 
the null given an observation p(H0|Obs≥t) that is then taken as an 
indication for p(H0) (see Nickerson, 2000).
Neyman-Pearson, hypothesis testing, and the α-value
Neyman & Pearson (1933) proposed a framework of statistical 
inference for applied decision making and quality control. In such 
framework, two hypotheses are proposed: the null hypothesis of 
no effect and the alternative hypothesis of an effect, along with 
a control of the long run probabilities of making errors. The first 
key concept in this approach, is the establishment of an alternative 
hypothesis along with an a priori effect size. This differs mark-
edly from Fisher who proposed a general approach for scientific 
inference conditioned on the null hypothesis only. The second key 
concept is the control of error rates. Neyman & Pearson (1928) 
introduced the notion of critical intervals, therefore dichotomizing 
the space of possible observations into correct vs. incorrect zones. 
This dichotomization allows distinguishing correct results (reject-
ing H0 when there is an effect and not rejecting H0 when there is 
no effect) from errors (rejecting H0 when there is no effect, the 
type I error, and not rejecting H0 when there is an effect, the type 
II error). In this context, alpha is the probability of committing a 
Type I error in the long run. Alternatively, Beta is the probability of 
committing a Type II error in the long run.
The (theoretical) difference in terms of hypothesis testing between 
Fisher and Neyman-Pearson is illustrated on Figure 1. In the 1st 
case, we choose a level of significance for observed data of 5%, and 
compute the p-value. If the p-value is below the level of signifi-
cance, it is used to reject H0. In the 2nd case, we set a critical interval 
      Amendments from Version 2
This version 3 includes minor changes that reflect the 3rd reviewers’ 
comments - in particular the theoretical vs. practical difference 
between Fisher and Neyman-Pearson. Additional information and 
reference is also included regarding the interpretation of p-value 
for low powered studies.
See referee reports
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based on the a priori effect size and error rates. If an observed 
statistic value is below and above the critical values (the bounds 
of the confidence region), it is deemed significantly different 
from H0. In the NHST framework, the level of significance is (in 
practice) assimilated to the alpha level, which appears as a simple 
decision rule: if the p-value is less or equal to alpha, the null is 
rejected. It is however a common mistake to assimilate these two 
concepts. The level of significance set for a given sample is not 
the same as the frequency of acceptance alpha found on repeated 
sampling because alpha (a point estimate) is meant to reflect the 
long run probability whilst the p-value (a cumulative estimate) 
reflects the current probability (Fisher, 1955; Hubbard & Bayarri, 
2003).
Acceptance or rejection of H0?
The acceptance level α can also be viewed as the maximum prob-
ability that a test statistic falls into the rejection region when the 
null hypothesis is true (Johnson, 2013). Therefore, one can only 
reject the null hypothesis if the test statistics falls into the critical 
region(s), or fail to reject this hypothesis. In the latter case, all 
we can say is that no significant effect was observed, but one 
cannot conclude that the null hypothesis is true. This is another 
common mistake in using NHST: there is a profound difference 
between accepting the null hypothesis and simply failing to reject it 
(Killeen, 2005). By failing to reject, we simply continue to assume 
that H0 is true, which implies that one cannot argue against a theory 
from a non-significant result (absence of evidence is not evidence 
of absence). To accept the null hypothesis, tests of equivalence 
(Walker & Nowacki, 2011) or Bayesian approaches (Dienes, 2014; 
Kruschke, 2011) must be used.
Confidence intervals
Confidence intervals (CI) are builds that fail to cover the true value 
at a rate of alpha, the Type I error rate (Morey & Rouder, 2011) 
and therefore indicate if observed values can be rejected by a (two 
tailed) test with a given alpha. CI have been advocated as alter-
natives to p-values because (i) they allow judging the statistical 
significance and (ii) provide estimates of effect size. Assuming the 
CI (a)symmetry and width are correct (but see Wilcox, 2012), they 
also give some indication about the likelihood that a similar value 
can be observed in future studies. For future studies of the same 
sample size, 95% CI give about 83% chance of replication success 
(Cumming & Maillardet, 2006). If sample sizes however differ 
between studies, CI do not however warranty any a priori coverage.
Figure 1. Illustration of the difference between the Fisher and Neyman-Pearson procedures. The figure was prepared with G-power for a 
one-sided one-sample t-test, with a sample size of 32 subjects, an effect size of 0.45, and error rates alpha=0.049 and beta=0.80. In Fisher’s 
procedure, only the nil-hypothesis is posed, and the observed p-value is compared to an a priori level of significance. If the observed p-value 
is below this level (here p=0.05), one rejects H0. In Neyman-Pearson’s procedure, the null and alternative hypotheses are specified along with 
an a priori level of acceptance. If the observed statistical value is outside the critical region (here [-∞ +1.69]), one rejects H0.
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Although CI provide more information, they are not less subject to 
interpretation errors (see Savalei & Dunn, 2015 for a review). The 
most common mistake is to interpret CI as the probability that a 
parameter (e.g. the population mean) will fall in that interval X% 
of the time. The correct interpretation is that, for repeated measure-
ments with the same sample sizes, taken from the same population, 
X% of times the CI obtained will contain the true parameter value 
(Tan & Tan, 2010). The alpha value has the same interpretation as 
testing against H0, i.e. we accept that 1-alpha CI are wrong in alpha 
percent of the times in the long run. This implies that CI do not 
allow to make strong statements about the parameter of interest 
(e.g. the mean difference) or about H1 (Hoekstra et al., 2014). To 
make a statement about the probability of a parameter of interest 
(e.g. the probability of the mean), Bayesian intervals must be used.
The (correct) use of NHST
NHST has always been criticized, and yet is still used every day 
in scientific reports (Nickerson, 2000). One question to ask oneself 
is what is the goal of a scientific experiment at hand? If the goal 
is to establish a discrepancy with the null hypothesis and/or estab-
lish a pattern of order, because both requires ruling out equiva-
lence, then NHST is a good tool (Frick, 1996; Walker & Now-
acki, 2011). If the goal is to test the presence of an effect and/or 
establish some quantitative values related to an effect, then NHST 
is not the method of choice since testing is conditioned on H0.
While a Bayesian analysis is suited to estimate that the probability 
that a hypothesis is correct, like NHST, it does not prove a theory 
on itself, but adds its plausibility (Lindley, 2000). No matter what 
testing procedure is used and how strong results are, (Fisher, 1959 
p13) reminds us that ‘ […] no isolated experiment, however sig-
nificant in itself, can suffice for the experimental demonstration 
of any natural phenomenon’. Similarly, the recent statement of 
the American Statistical Association (Wasserstein & Lazar, 2016) 
makes it clear that conclusions should be based on the researchers 
understanding of the problem in context, along with all summary 
data and tests, and that no single value (being p-values, Bayesian 
factor or else) can be used support or invalidate a theory.
What to report and how?
Considering that quantitative reports will always have more infor-
mation content than binary (significant or not) reports, we can 
always argue that raw and/or normalized effect size, confidence 
intervals, or Bayes factor must be reported. Reporting everything 
can however hinder the communication of the main result(s), 
and we should aim at giving only the information needed, at 
least in the core of a manuscript. Here I propose to adopt opti-
mal reporting in the result section to keep the message clear, but 
have detailed supplementary material. When the hypothesis is 
about the presence/absence or order of an effect, and provid-
ing that a study has sufficient power, NHST is appropriate and it 
is sufficient to report in the text the actual p-value since it con-
veys the information needed to rule out equivalence. When the 
hypothesis and/or the discussion involve some quantitative value, 
and because p-values do not inform on the effect, it is essential to 
report on effect sizes (Lakens, 2013), preferably accompanied with 
confidence or credible intervals. The reasoning is simply that one 
cannot predict and/or discuss quantities without accounting for 
variability. For the reader to understand and fully appreciate the 
results, nothing else is needed.
Because science progress is obtained by cumulating evidence 
(Rosenthal, 1991), scientists should also consider the secondary 
use of the data. With today’s electronic articles, there are no rea-
sons for not including all of derived data: mean, standard devia-
tions, effect size, CI, Bayes factor should always be included as 
supplementary tables (or even better also share raw data). It is also 
essential to report the context in which tests were performed – that 
is to report all of the tests performed (all t, F, p values) because of 
the increase type one error rate due to selective reporting (multiple 
comparisons and p-hacking problems - Ioannidis, 2005). Providing 
all of this information allows (i) other researchers to directly and 
effectively compare their results in quantitative terms (replication 
of effects beyond significance, Open Science Collaboration, 2015), 
(ii) to compute power to future studies (Lakens & Evers, 2014), 
and (iii) to aggregate results for meta-analyses whilst minimizing 
publication bias (van Assen et al., 2014).
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doi:10.5256/f1000research.9903.r16257
 Stephen J. Senn
Luxembourg Institute of Health, Strassen, L-1445, Luxembourg
On the whole I think that this article is reasonable, my main reservation being that I have my doubts on
whether the literature needs yet another tutorial on this subject.
A further reservation I have is that the author, following others, stresses what in my mind is a relatively
unimportant distinction between the Fisherian and Neyman-Pearson (NP) approaches. The distinction
stressed by many is that the NP approach leads to a dichotomy accept/reject based on probabilities
established in advance, whereas the Fisherian approach uses tail area probabilities calculated from the
observed statistic. I see this as being unimportant and not even true. Unless one considers that the
person carrying out a hypothesis test (original tester) is mandated to come to a conclusion on behalf of all
scientific posterity, then one must accept that any remote scientist can come to his or her conclusion
depending on the personal type I error favoured. To operate the results of an NP test carried out by the
original tester, the remote scientist then needs to know the p-value. The type I error rate is then compared
to this to come to a personal accept or reject decision (1). In fact Lehmann (2), who was an important
developer of and proponent of the NP system, describes exactly this approach as being good practice.
(See Testing Statistical Hypotheses, 2nd edition P70). Thus using tail-area probabilities calculated from
the observed statistics does not constitute an operational difference between the two systems.
A more important distinction between the Fisherian and NP systems is that the former does not use
alternative hypotheses(3). Fisher's opinion was that the null hypothesis was more primitive than the test
statistic but that the test statistic was more primitive than the alternative hypothesis. Thus, alternative
hypotheses could not be used to justify choice of test statistic. Only experience could do that.
Further distinctions between the NP and Fisherian approach are to do with conditioning and whether a
null hypothesis can ever be accepted.
I have one minor quibble about terminology. As far as I can see, the author uses the usual term 'null
hypothesis' and the eccentric term 'nil hypothesis' interchangeably. It would be simpler if the latter were
abandoned.
References
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Version 1
 10 November 2015Referee Report
doi:10.5256/f1000research.7499.r11036
 Marcel ALM van Assen
Department of Methodology and Statistics, Tilburgh University, Tilburg, Netherlands
Null hypothesis significance testing (NHST) is a difficult topic, with misunderstandings arising easily.
Many texts, including basic statistics books, deal with the topic, and attempt to explain it to students and
anyone else interested. I would refer to a good basic text book, for a detailed explanation of NHST, or to a
specialized article when wishing an explaining the background of NHST. So, what is the added value of a
new text on NHST? In any case, the added value should be described at the start of this text. Moreover,
the topic is so delicate and difficult that errors, misinterpretations, and disagreements are easy. I
attempted to show this by giving comments to many sentences in the text.
Abstract: “null hypothesis significance testing is the statistical method of choice in biological, biomedical
and social sciences to investigate if an effect is likely”. No, NHST is the method to test the hypothesis of
no effect.
Intro: “Null hypothesis significance testing (NHST) is a method of statistical inference by which an
observation is tested against a hypothesis of no effect or no relationship.” What is an ‘observation’? NHST
is difficult to describe in one sentence, particularly here. I would skip this sentence entirely, here.
Section on Fisher; also explain the one-tailed test.
Section on Fisher; p(Obs|H0) does not reflect the verbal definition (the ‘or more extreme’ part).
Section on Fisher; use a reference and citation to Fisher’s interpretation of the p-value
Section on Fisher; “This was however only intended to be used as an indication that there is something in
the data that deserves further investigation. The reason for this is that only H0 is tested whilst the effect
under study is not itself being investigated.” First sentence, can you give a reference? Many people say a
lot about Fisher’s intentions, but the good man is dead and cannot reply… Second sentence is a bit
awkward, because the effect  investigated in a way, by testing the H0.is
Section on p-value; Layout and structure can be improved greatly, by first again stating what the p-value
is, and then statement by statement, what it is not, using separate lines for each statement. Consider
adding that the p-value is randomly distributed under H0 (if all the assumptions of the test are met), and
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is, and then statement by statement, what it is not, using separate lines for each statement. Consider
adding that the p-value is randomly distributed under H0 (if all the assumptions of the test are met), and
that under H1 the p-value is a function of population effect size and N; the larger each is, the smaller the
p-value generally is.
Skip the sentence “If there is no effect, we should replicate the absence of effect with a probability equal
to 1-p”. Not insightful, and you did not discuss the concept ‘replicate’ (and do not need to).
Skip the sentence “The total probability of false positives can also be obtained by aggregating results (
).” Not strongly related to p-values, and introduces unnecessary concepts ‘false positives’Ioannidis, 2005
(perhaps later useful) and ‘aggregation’.
Consider deleting; “If there is an effect however, the probability to replicate is a function of the (unknown)
population effect size with no good way to know this from a single experiment ( ).”Killeen, 2005
The following sentence; “ Finally, a (small) p-value . A lowis not an indication favouring a hypothesis
p-value indicates a misfit of the null hypothesis to the data and cannot be taken as evidence in favour of a
specific alternative hypothesis more than any other possible alternatives such as measurement error and
selection bias ( ).” is surely not mainstream thinking about NHST; I would surely delete thatGelman, 2013
sentence. In NHST, a p-value is used for testing the H0. Why did you not yet discuss significance level?
Yes, before discussing what is not a p-value, I would explain NHST (i.e., what it is and how it is used). 
Also the next sentence “The more (a priori) implausible the alternative hypothesis, the greater the chance
that a finding is a false alarm ( ; ).“ is not fully clear to me. This is aKrzywinski & Altman, 2013 Nuzzo, 2014
Bayesian statement. In NHST, no likelihoods are attributed to hypotheses; the reasoning is “IF H0 is true,
then…”.
Last sentence: “As  puts it ‘theory corroboration requires the testing of multipleNickerson (2000)
predictions because the chance of getting statistically significant results for the wrong reasons in any
given case is high’.” What is relation of this sentence to the contents of this section, precisely?
Next section: “For instance, we can estimate that the probability of a given F value to be in the critical
interval [+2 +∞] is less than 5%” This depends on the degrees of freedom.
“When there is no effect (H0 is true), the erroneous rejection of H0 is known as type I error and is equal to
the p-value.” Strange sentence. The Type I error is the probability of erroneously rejecting the H0 (so,
when it is true). The p-value is … well, you explained it before; it surely does not equal the Type I error.
Consider adding a figure explaining the distinction between Fisher’s logic and that of Neyman and
Pearson.
“When the test statistics falls outside the critical region(s)” What is outside?
“There is a profound difference between accepting the null hypothesis and simply failing to reject it (
)” I agree with you, but perhaps you may add that some statisticians simply define “acceptKilleen, 2005
H0’” as obtaining a p-value larger than the significance level. Did you already discuss the significance
level, and it’s mostly used values?
“To accept or reject equally the null hypothesis, Bayesian approaches ( ; ) orDienes, 2014 Kruschke, 2011
confidence intervals must be used.” Is ‘reject equally’ appropriate English? Also using Cis, one cannot
accept the H0.
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accept the H0.
Do you start discussing alpha only in the context of Cis?
“CI also indicates the precision of the estimate of effect size, but unless using a percentile bootstrap
approach, they require assumptions about distributions which can lead to serious biases in particular
regarding the symmetry and width of the intervals ( ).” Too difficult, using new concepts.Wilcox, 2012
Consider deleting.
“Assuming the CI (a)symmetry and width are correct, this gives some indication about the likelihood that a
similar value can be observed in future studies, with 95% CI giving about 83% chance of replication
success ( ).” This statement is, in general, completely false. It very much dependsLakens & Evers, 2014
on the sample sizes of both studies. If the replication study has a much, much, much larger N, then the
probability that the original CI will contain the effect size of the replication approaches (1-alpha)*100%. If
the original study has a much, much, much larger N, then the probability that the original Ci will contain the
effect size of the replication study approaches 0%.
“Finally, contrary to p-values, CI can be used to accept H0. Typically, if a CI includes 0, we cannot reject
H0. If a critical null region is specified rather than a single point estimate, for instance [-2 +2] and the CI is
included within the critical null region, then H0 can be accepted. Importantly, the critical region must be
specified a priori and cannot be determined from the data themselves.” No. H0 cannot be accepted with
Cis.
“The (posterior) probability of an effect can however not be obtained using a frequentist framework.”
Frequentist framework? You did not discuss that, yet.
“X% of times the CI obtained will contain the same parameter value”. The same? True, you mean?
“e.g. X% of the times the CI contains the same mean” I do not understand; which mean?
“The alpha value has the same interpretation as when using H0, i.e. we accept that 1-alpha CI are wrong
in alpha percent of the times. “ What do you mean, CI are wrong? Consider rephrasing.
“To make a statement about the probability of a parameter of interest, likelihood intervals (maximum
likelihood) and credibility intervals (Bayes) are better suited.” ML gives the likelihood of the data given the
parameter, not the other way around.
“Many of the disagreements are not on the method itself but on its use.” Bayesians may disagree.
“If the goal is to establish the likelihood of an effect and/or establish a pattern of order, because both
requires ruling out equivalence, then NHST is a good tool ( )” NHST does not provide evidenceFrick, 1996
on the likelihood of an effect.
“If the goal is to establish some quantitative values, then NHST is not the method of choice.” P-values are
also quantitative… this is not a precise sentence. And NHST may be used in combination with effect size
estimation (this is even recommended by, e.g., the American Psychological Association (APA)).
“Because results are conditioned on H0, NHST cannot be used to establish beliefs.” It can reinforce some
beliefs, e.g., if H0 or any other hypothesis, is true.
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“To estimate the probability of a hypothesis, a Bayesian analysis is a better alternative.” It is the only
alternative?
“Note however that even when a specific quantitative prediction from a hypothesis is shown to be true
(typically testing H1 using Bayes), it does not prove the hypothesis itself, it only adds to its plausibility.”
How can we  something is true?show
I do not agree on the contents of the last section on ‘minimal reporting’. I prefer ‘optimal reporting’ instead,
i.e., the reporting the information that is essential to the interpretation of the result, to any ready, which
may have other goals than the writer of the article. This reporting includes, for sure, an estimate of effect
size, and preferably a confidence interval, which is in line with recommendations of the APA.
I have read this submission. I believe that I have an appropriate level of expertise to state that I
do not consider it to be of an acceptable scientific standard, for reasons outlined above.
 No competing interests were disclosed.Competing Interests:
Author Response 06 Jul 2016
, The University of Edinburgh, UKCyril Pernet
Null hypothesis significance testing (NHST) is a difficult topic, with misunderstandings
arising easily. Many texts, including basic statistics books, deal with the topic, and attempt
to explain it to students and anyone else interested. I would refer to a good basic text book,
for a detailed explanation of NHST, or to a specialized article when wishing an explaining
the background of NHST. So, what is the added value of a new text on NHST? In any case,
the added value should be described at the start of this text. Moreover, the topic is so
delicate and difficult that errors, misinterpretations, and disagreements are easy. I
attempted to show this by giving comments to many sentences in the text.
The idea of this short review was to point to common interpretation errors (stressing again
and again that we are under H0) being in using p-values or CI, and also proposing reporting
practices to avoid bias. This is now stated at the end of abstract.
Regarding text books, it is clear that many fail to clearly distinguish Fisher/Pearson/NHST,
see Glinet et al (2012) J. Exp Education 71, 83-92. If you have 1 or 2 in mind that you know
to be good, I’m happy to include them.
 
Abstract: “null hypothesis significance testing is the statistical method of choice in biological,
biomedical and social sciences to investigate if an effect is likely”. No, NHST is the method
to test the hypothesis of no effect.
I agree – yet people use it to investigate (not test) if an effect is likely. The issue here is
wording. What about adding this distinction at the end of the sentence?: ‘null hypothesis
significance testing is the statistical method of choice in biological, biomedical and social
sciences used to investigate if an effect is likely, even though it actually tests for the
hypothesis of no effect’.
 
Intro: “Null hypothesis significance testing (NHST) is a method of statistical inference by
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Intro: “Null hypothesis significance testing (NHST) is a method of statistical inference by
which an observation is tested against a hypothesis of no effect or no relationship.” What is
an ‘observation’? NHST is difficult to describe in one sentence, particularly here. I would
skip this sentence entirely, here.
I think a definition is needed, as it offers a starting point. What about the following: ‘NHST is
a method of statistical inference by which an experimental factor is tested against a
hypothesis of no effect or no relationship based on a given observation’
 
Section on Fisher; also explain the one-tailed test.
Section on Fisher; p(Obs|H0) does not reflect the verbal definition (the ‘or more extreme’
part).
Section on Fisher; use a reference and citation to Fisher’s interpretation of the p-value
Section on Fisher; “This was however only intended to be used as an indication that there is
something in the data that deserves further investigation. The reason for this is that only H0
is tested whilst the effect under study is not itself being investigated.” First sentence, can
you give a reference? Many people say a lot about Fisher’s intentions, but the good man is
dead and cannot reply… Second sentence is a bit awkward, because the effect is
investigated in a way, by testing the H0.
The section on Fisher has been modified (more or less) as suggested: (1) avoiding talking
about one or two tailed tests (2) updating for p(Obs≥t|H0) and (3) referring to Fisher more
explicitly (ie pages from articles and book) ; I cannot tell his intentions but these quotes
leave little space to alternative interpretations.
 
Section on p-value; Layout and structure can be improved greatly, by first again stating what
the p-value is, and then statement by statement, what it is not, using separate lines for each
statement. Consider adding that the p-value is randomly distributed under H0 (if all the
assumptions of the test are met), and that under H1 the p-value is a function of population
effect size and N; the larger each is, the smaller the p-value generally is.
Done
 
Skip the sentence “If there is no effect, we should replicate the absence of effect with a
probability equal to 1-p”. Not insightful, and you did not discuss the concept ‘replicate’ (and
do not need to).
Done
 
Skip the sentence “The total probability of false positives can also be obtained by
aggregating results (Ioannidis, 2005).” Not strongly related to p-values, and introduces
unnecessary concepts ‘false positives’ (perhaps later useful) and ‘aggregation’.
Done
 
Consider deleting; “If there is an effect however, the probability to replicate is a function of
the (unknown) population effect size with no good way to know this from a single experiment
(Killeen, 2005).”
Done
Page 12 of 19




The following sentence; “ Finally, a (small) p-value is not an indication favouring a
hypothesis. A low p-value indicates a misfit of the null hypothesis to the data and cannot be
taken as evidence in favour of a specific alternative hypothesis more than any other
possible alternatives such as measurement error and selection bias ( ).” isGelman, 2013
surely not mainstream thinking about NHST; I would surely delete that sentence. In NHST, a
p-value is used for testing the H0. Why did you not yet discuss significance level? Yes,
before discussing what is not a p-value, I would explain NHST (i.e., what it is and how it is
used). 
Also the next sentence “The more (a priori) implausible the alternative hypothesis, the
greater the chance that a finding is a false alarm ( ; ).“Krzywinski & Altman, 2013 Nuzzo, 2014
is not fully clear to me. This is a Bayesian statement. In NHST, no likelihoods are attributed
to hypotheses; the reasoning is “IF H0 is true, then…”.
The reasoning here is as you state yourself, part 1: ‘a p-value is used for testing the H0; and
part 2: ‘no likelihoods are attributed to hypotheses’ it follows we cannot favour a hypothesis.
It might seems contentious but this is the case that all we can is to reject the null – how
could we favour a specific alternative hypothesis from there? This is explored further down
the manuscript (and I now point to that) – note that we do not need to be Bayesian to favour
a specific H1, all I’m saying is this cannot be attained with a p-value.
 
Last sentence: “As Nickerson (2000) puts it ‘theory corroboration requires the testing of
multiple predictions because the chance of getting statistically significant results for the
wrong reasons in any given case is high’.” What is relation of this sentence to the contents
of this section, precisely?
The point was to emphasise that a p value is not there to tell us a given H1 is true and can
only be achieved through multiple predictions and experiments. I deleted it for clarity.
 
Next section: “For instance, we can estimate that the probability of a given F value to be in
the critical interval [+2 +∞] is less than 5%” This depends on the degrees of freedom.
This sentence has been removed
 
“When there is no effect (H0 is true), the erroneous rejection of H0 is known as type I error
and is equal to the p-value.” Strange sentence. The Type I error is the probability of
erroneously rejecting the H0 (so, when it is true). The p-value is … well, you explained it
before; it surely does not equal the Type I error.
Indeed, you are right and I have modified the text accordingly. When there is no effect (H0 is
true), the erroneous rejection of H0 is known as type 1 error. Importantly, the type 1 error
rate, or alpha value is determined a priori. It is a common mistake but the level of
significance (for a given sample) is not the same as the frequency of acceptance alpha
found on repeated sampling (Fisher, 1955).
 
Consider adding a figure explaining the distinction between Fisher’s logic and that of
Neyman and Pearson.
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A figure is now presented – with levels of acceptance, critical region, level of significance
and p-value.
 
“When the test statistics falls outside the critical region(s)” What is outside?
“There is a profound difference between accepting the null hypothesis and simply failing to
reject it ( )” I agree with you, but perhaps you may add that some statisticiansKilleen, 2005
simply define “accept H0’” as obtaining a p-value larger than the significance level. Did you
already discuss the significance level, and it’s mostly used values?
“To accept or reject equally the null hypothesis, Bayesian approaches ( ; Dienes, 2014
) or confidence intervals must be used.” Is ‘reject equally’ appropriateKruschke, 2011
English? Also using Cis, one cannot accept the H0.
I should have clarified further here – as I was having in mind tests of equivalence. To clarify,
I simply states now: ‘To accept the null hypothesis, tests of equivalence or Bayesian
approaches must be used.’
 
Do you start discussing alpha only in the context of Cis?
It is now presented in the paragraph before.
 
“CI also indicates the precision of the estimate of effect size, but unless using a percentile
bootstrap approach, they require assumptions about distributions which can lead to serious
biases in particular regarding the symmetry and width of the intervals ( ).” TooWilcox, 2012
difficult, using new concepts. Consider deleting.
Done
 
“Assuming the CI (a)symmetry and width are correct, this gives some indication about the
likelihood that a similar value can be observed in future studies, with 95% CI giving about
83% chance of replication success ( ).” This statement is, in general,Lakens & Evers, 2014
completely false. It very much depends on the sample sizes of both studies. If the replication
study has a much, much, much larger N, then the probability that the original CI will contain
the effect size of the replication approaches (1-alpha)*100%. If the original study has a
much, much, much larger N, then the probability that the original Ci will contain the effect
size of the replication study approaches 0%.
Yes, you are right, I completely overlooked this problem. The corrected sentence (with more
accurate ref) is now “Assuming the CI (a)symmetry and width are correct, this gives some
indication about the likelihood that a similar value can be observed in future studies. For
future studies of the same sample size, 95% CI giving about 83% chance of replication
success (Cumming and Mallardet, 2006). If sample sizes differ between studies, CI do not
however warranty any a priori coverage”. 
 
“Finally, contrary to p-values, CI can be used to accept H0. Typically, if a CI includes 0, we
cannot reject H0. If a critical null region is specified rather than a single point estimate, for
instance [-2 +2] and the CI is included within the critical null region, then H0 can be
accepted. Importantly, the critical region must be specified a priori and cannot be
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accepted. Importantly, the critical region must be specified a priori and cannot be
determined from the data themselves.” No. H0 cannot be accepted with Cis.
Again, I had in mind equivalence testing, but in both cases you are right we can only reject
and I therefore removed that sentence.
 
“The (posterior) probability of an effect can however not be obtained using a frequentist
framework.” Frequentist framework? You did not discuss that, yet.
Removed
 
“X% of times the CI obtained will contain the same parameter value”. The same? True, you
mean?
“e.g. X% of the times the CI contains the same mean” I do not understand; which mean?
“The alpha value has the same interpretation as when using H0, i.e. we accept that 1-alpha
CI are wrong in alpha percent of the times. “ What do you mean, CI are wrong? Consider
rephrasing.
“To make a statement about the probability of a parameter of interest, likelihood intervals
(maximum likelihood) and credibility intervals (Bayes) are better suited.” ML gives the
likelihood of the data given the parameter, not the other way around.
corrected
 




“If the goal is to establish the likelihood of an effect and/or establish a pattern of order,
because both requires ruling out equivalence, then NHST is a good tool ( )”Frick, 1996
NHST does not provide evidence on the likelihood of an effect.
“If the goal is to establish some quantitative values, then NHST is not the method of choice.”
P-values are also quantitative… this is not a precise sentence. And NHST may be used in
combination with effect size estimation (this is even recommended by, e.g., the American
Psychological Association (APA)).
Yes, p-values must be interpreted in context with effect size, but this is not what people do.
The point here is to be pragmatic, does and don’t. The sentence was changed.
 
“Because results are conditioned on H0, NHST cannot be used to establish beliefs.” It can
reinforce some beliefs, e.g., if H0 or any other hypothesis, is true.
“To estimate the probability of a hypothesis, a Bayesian analysis is a better alternative.” It is
the only alternative?
Not for testing, but for probability, I am not aware of anything else.
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Not for testing, but for probability, I am not aware of anything else.
 
“Note however that even when a specific quantitative prediction from a hypothesis is shown
to be true (typically testing H1 using Bayes), it does not prove the hypothesis itself, it only
adds to its plausibility.” How can we show something is true?
Cumulative evidence is, in my opinion, the only way to show it. Even in hard science like
physics multiple experiments. In the recent CERN study on finding Higgs bosons, 2 different
and complementary experiments ran in parallel – and the cumulative evidence was taken as
a proof of the true existence of Higgs bosons.
 No competing interests were disclosed.Competing Interests:
 30 October 2015Referee Report
doi:10.5256/f1000research.7499.r10159
 Daniel Lakens
School of Innovation Sciences, Eindhoven University of Technology, Eindhoven, Netherlands
I appreciate the author's attempt to write a short tutorial on NHST. Many people don't know how to use it,
so attempts to educate people are always worthwhile. However, I don't think the current article reaches
it's aim. For one, I think it might be practically impossible to explain a lot in such an ultra short paper -
every section would require more than 2 pages to explain, and there are many sections. Furthermore,
there are some excellent overviews, which, although more extensive, are also much clearer (e.g., 
). Finally, I found many statements to be unclear, and perhaps even incorrect (notedNickerson, 2000
below). Because there is nothing worse than creating more confusion on such a topic, I have extremely
high standards before I think such a short primer should be indexed. I note some examples of unclear or
incorrect statements below. I'm sorry I can't make a more positive recommendation.
“investigate if an effect is likely” – ambiguous statement. I think you mean, whether the observed DATA is
probable, assuming there is no effect?
The Fisher (1959) reference is not correct – Fischer developed his method much earlier.
“This p-value thus reflects the conditional probability of achieving the observed outcome or larger,
p(Obs|H0)” – please add 'assuming the null-hypothesis is true'.
“p(Obs|H0)” – explain this notation for novices.
“Following Fisher, the smaller the p-value, the greater the likelihood that the null hypothesis is false.”  This
is wrong, and any statement about this needs to be much more precise. I would suggest direct quotes.
“there is something in the data that deserves further investigation” –unclear sentence.
“The reason for this” – unclear what ‘this’ refers to.
“ – second of can be removed?not the probability of the null hypothesis of being true, p(H0)” 
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“ – second of can be removed?not the probability of the null hypothesis of being true, p(H0)” 
“Any interpretation of the p-value in relation to the effect under study (strength, reliability, probability) is
indeed
wrong, since the p-value is conditioned on H0”  - incorrect. A big problem is that it depends on the sample
size, and that the probability of a theory depends on the prior.
“If there is no effect, we should replicate the absence of effect with a probability equal to 1-p.” I don’t
understand this, but I think it is incorrect.
“The total probability of false positives can also be obtained by aggregating results (Ioannidis, 2005).”
Unclear, and probably incorrect.
“By failing to reject, we simply continue to assume that H0 is true, which implies that one cannot, from a
nonsignificant result, argue against a theory” – according to which theory? From a NP perspective, you
can ACT as if the theory is false.
“(Lakens & Evers, 2014”) – we are not the original source, which should be cited instead.
“ Typically, if a CI includes 0, we cannot reject H0.”  - when would this not be the case? This assumes a CI
of 1-alpha.
“If a critical null region is specified rather than a single point estimate, for instance [-2 +2] and the CI is
included within the critical null region, then H0 can be accepted.” – you mean practically, or formally? I’m
pretty sure only the former.
The section on ‘The (correct) use of NHST’ seems to conclude only Bayesian statistics should be used. I 
don’t really agree.
we can always argue that effect size, power, etc. must be reported.” – which power? Post-hoc power?“
Surely not? Other types are unknown. So what do you mean?
The recommendation on what to report remains vague, and it is unclear why what should be reported.
I have read this submission. I believe that I have an appropriate level of expertise to state that I
do not consider it to be of an acceptable scientific standard, for reasons outlined above.
 No competing interests were disclosed.Competing Interests:
Author Response 06 Jul 2016
, The University of Edinburgh, UKCyril Pernet
“investigate if an effect is likely” – ambiguous statement. I think you mean, whether the
observed DATA is probable, assuming there is no effect?
This sentence was changed, following as well the other reviewer, to ‘null hypothesis
significance testing is the statistical method of choice in biological, biomedical and social
sciences to investigate if an effect is likely, even though it actually tests whether the
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sciences to investigate if an effect is likely, even though it actually tests whether the
observed data are probable, assuming there is no effect’
 
The Fisher (1959) reference is not correct – Fischer developed his method much earlier.
Changed, refers to Fisher 1925
 
“This p-value thus reflects the conditional probability of achieving the observed outcome or
larger, p(Obs|H0)” – please add 'assuming the null-hypothesis is true'. “p(Obs|H0)” – explain
this notation for novices.
I changed a little the sentence structure, which should make explicit that this is the condition
probability.
 
“Following Fisher, the smaller the p-value, the greater the likelihood that the null hypothesis
is false.”  This is wrong, and any statement about this needs to be much more precise. I
would suggest direct quotes.
This sentence has been removed
 
“there is something in the data that deserves further investigation” –unclear sentence. “The
reason for this” – unclear what ‘this’ refers to.
This has been changed to ‘[…] to decide whether the evidence is worth additional
investigation and/or replication (Fisher, 1971 p13)’
 
“not the probability of the null hypothesis of being true, p(H0)” – second of can be removed?
my mistake – the sentence structure is now ‘not the probability of the null hypothesis p(H0),
of being true,’ ; hope this makes more sense (and this way refers back to p(Obs>t|H0)
 
“Any interpretation of the p-value in relation to the effect under study (strength, reliability,
probability) is indeed wrong, since the p-value is conditioned on H0”  - incorrect. A big
problem is that it depends on the sample size, and that the probability of a theory depends
on the prior.
Fair enough – my point was to stress the fact that p value and effect size or H1 have very
little in common, but yes that the part in common has to do with sample size. I left the
conditioning on H0 but also point out the dependency on sample size.
 
“If there is no effect, we should replicate the absence of effect with a probability equal to
1-p.” I don’t understand this, but I think it is incorrect.
Removed
 
“The total probability of false positives can also be obtained by aggregating results
(Ioannidis, 2005).” Unclear, and probably incorrect.
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“By failing to reject, we simply continue to assume that H0 is true, which implies that one
cannot, from a nonsignificant result, argue against a theory” – according to which theory?
From a NP perspective, you can ACT as if the theory is false.
The whole paragraph was changed to reflect a more philosophical take on scientific
induction/reasoning. I hope this is clearer.
 
“(Lakens & Evers, 2014”) – we are not the original source, which should be cited instead.
done
 
“ Typically, if a CI includes 0, we cannot reject H0.”  - when would this not be the case? This
assumes a CI of 1-alpha. “If a critical null region is specified rather than a single point
estimate, for instance [-2 +2] and the CI is included within the critical null region, then H0
can be accepted.” – you mean practically, or formally? I’m pretty sure only the former.
Changed to refer to equivalence testing
 
The section on ‘The (correct) use of NHST’ seems to conclude only Bayesian statistics
should be used. I don’t really agree.
I rewrote this, as to show frequentist analysis can be used  - I’m trying to sell Bayes more
than any other approach.
 
we can always argue that effect size, power, etc. must be reported.” – which power?“
Post-hoc power? Surely not? Other types are unknown. So what do you mean? The
recommendation on what to report remains vague, and it is unclear why what should be
reported.
I’m arguing we should report it all, that’s why there is no exhausting list – I can if needed.
 No competing interests were disclosed.Competing Interests:
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